LIPOCINE INC (LPCN:NASDAQ)
$2.41 0.21 (9.5455%)
Analysed LIPOCINE INC (LPCN:NASDAQ) News Sources
Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression
02-04-2026
yahoo.com
Lipocine Announces Financial Results for the Full Year Ended December 31, 2025
10-03-2026
yahoo.com
Lipocine: Q4 Earnings Snapshot
10-03-2026
yahoo.com
Lipocine (LPCN) Soars 5.5%: Is Further Upside Left in the Stock?
27-02-2026
yahoo.com
Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates
26-02-2026
yahoo.com
Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)
18-02-2026
yahoo.com
Buy Rating Maintained on Lipocine Inc. (LPCN) as Target Climbs to $15
11-02-2026
yahoo.com
Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)
20-01-2026
yahoo.com
Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)
12-01-2026
yahoo.com
Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone
16-12-2025
yahoo.com
What is the current price of LIPOCINE INC (LPCN:NASDAQ)?
The current price of LIPOCINE INC (LPCN:NASDAQ) is $2.41.
LIPOCINE INC (LPCN:NASDAQ) absolute price change since previous trading day?
The absolute price change of LIPOCINE INC (LPCN:NASDAQ) since the previous trading day is $0.21.
LIPOCINE INC (LPCN:NASDAQ) percentage price change since previous trading day?
The percentage price change of LIPOCINE INC (LPCN:NASDAQ) since the previous trading day is 9.5455%.
What is the most recent average sentiment score for LIPOCINE INC (LPCN:NASDAQ)?
The most recent average sentiment score for LIPOCINE INC (LPCN:NASDAQ) is 64 out of 100.
What is the most recent average sentiment for LIPOCINE INC (LPCN:NASDAQ)?
The most recent sentiment for LIPOCINE INC (LPCN:NASDAQ) is .
SEC-8K** Filing Available For LIPOCINE INC (LPCN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.